Another blood pressure medicine recalled, this time it’s from Lupin Pharmaceuticals
Lupin Pharmaceuticals has issued a voluntary recall of Irbesartan Tablets, as well as Irbesartan and Hydrochlorothiazide Tablets due to increased levels of N-nitrosoirbesartan. N-nitrosoirbesartan is a known as a possible human carcinogen.
More than 75 lots of Lupin Pharmaceuticals tablets have been recalled. There are simply too many lots to list on this post, but we’ll provide a link below that will take you to the FDA’s page with all of the recalled lots. Wholesalers, distributors, and retailers nationwide have been informed of the recall. Any of these entities that still have Irbesartan Tablets or Irbesartan and Hydrochlorothiazide Tablets on their shelves should remove them and contact Lupin Pharmaceuticals immediately.
Possible human carcinogens are named as such because it’s been shown in studies that they may cause cancer. Customers prescribed the recalled tablets should continue to take them as directed by their physician. They should however seek advice from said physician on how to proceed moving forward.
For a complete list of the recalled lots and the FDA’s release on the recall, click here: https://bit.ly/3nwTDoL